US Pharma MarketingInvestment giants join forces to form largest healthcare firm on the globe - Pharmaceutical Technology
The new healthcare firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend. The new specialist firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend. The new firm will focus on “high-growth, innovation-led” healthcare investment opportunities, including AI-related projects. Credit: eamesBot / Shutterstock.com. Two key healthcare investors have merged to create the largest dedicated investment manager in their specialist sector, which will see the duo hold more than $21bn in combined assets. Through the deal between European…
The new healthcare firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend.
Source: Pharmaceutical Technology